Skip to main content

  • Start-ups race to develop Covid-19 immunity passports

    25 May, 2020
    European tech groups aim to deploy digital ID systems to certify those deemed safe to return to normal lifeAs the search for a vaccine for coronavirus continues, start-ups are racing to build digital ID systems to assign health statuses to individuals and identify those safe to reintegrate into normal life.So-called immunity passports work by linking a person’s identity to their coronavirus test results. Those deemed immune or clear of the virus can prove their status to authorities and emplo...
  • Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

    25 May, 2020
    Background
    Hydroxychloroquine or chloroquine, often in combination with a second-generation macrolide, are being widely used for treatment of COVID-19, despite no conclusive evidence of their benefit. Although generally safe when used for approved indications such as autoimmune disease or malaria, the safety and benefit of these treatment regimens are poorly evaluated in COVID-19.
    Methods
    We did a multinational registry analysis of the use of hydroxychloroquine or chloroquine with or...
  • Coronavirus cases, hospitalizations and ICU admissions in Spain at lowest level since March

    25 May, 2020

    The daily data covering the coronavirus epidemic in Spain continued in the same direction on Sunday, according to the latest figures supplied by the Health Ministry. Once again, the majority of indicators were at low levels, while there were continuing problems with the notification of the figures from the Catalonia region.

    New infections came in at 246, hospitalizations at 86, and new intensive care unit (ICU) admissions were at three – all of which were the lowest seen since Marc...
  • Oxford scientists working on a coronavirus vaccine say there is now only a 50% chance of success because the number of UK cases is falling too quickly

    25 May, 2020

    Scientists involved in one of the world's leading studies into finding a vaccine for the coronavirus say there is currently only a 50% chance of success because the number of people in Britain with the virus is falling too quickly.

    The Oxford University mission to find a vaccine for the COVID-19 virus is in "a race against the virus disappearing, and against time," Adam Hill, director at Oxford University's Jenner Institute, said this weekend.

    Hill told The Telegraph newspap...
  • Advitos medical devices being tested at the frontline of COVID-19 fight

    22 May, 2020
    Advitos, a Munich-based company supported by the EIT Digital Accelerator, offers a highly technological solution for treating multiple organ failure, which is currently being tested in Intensive Care Units, next to ventilators, to support the treatment of COVID-19 patients.
    Advitos's patented medical devices can support the simultaneous dialysis of three organs (i.e. kidneys, liver & lung) and adjust for blood pH balance. This device is currently being tested to support patients suffer...
  • EIT Community COVID-19 Response

    22 May, 2020
    This section presents the measures, activities and solutions powered by the EIT Community, Europe’s largest innovation ecosystem powering entrepreneurs and innovators, in response to the COVID-19 pandemic.
    Innovation plays a key role in responding to the significant challenges posed by the COVID-19 crisis. The world we live in is changing dramatically with significant changes to our society, how we look at opportunities and how we respond to challenges.

    The COVID-19 pandemic has sig...
  • EIT Community COVID-19 Response

    22 May, 2020
    This section presents the measures, activities and solutions powered by the EIT Community, Europe’s largest innovation ecosystem powering entrepreneurs and innovators, in response to the COVID-19 pandemic.
    Innovation plays a key role in responding to the significant challenges posed by the COVID-19 crisis. The world we live in is changing dramatically with significant changes to our society, how we look at opportunities and how we respond to challenges.

    The COVID-19 pandemic has sig...
  • Hydroxychloroquine trial begins in the UK

    22 May, 2020

    A trial to see whether two anti-malarial drugs could prevent Covid-19 has begun in Brighton and Oxford.

    Chloroquine, hydroxychloroquine or a placebo will be given to more than 40,000 healthcare workers from Europe, Africa, Asia and South America.

    All the participants are staff who are in contact with Covid-19 patients.

    Click here for reference








  • Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

    22 May, 2020
    Background
    No specific antiviral drug has been proven effective for treatment of patients with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside analogue prodrug, has inhibitory effects on pathogenic animal and human coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro, and inhibits Middle East respiratory syndrome coronavirus, SARS-CoV-1, and SARS-CoV-2 replication in animal models.
    Methods
    We did a randomised, d...
  • Just 7.3% of Stockholm had Covid-19 antibodies by end of April, study shows

    22 May, 2020
    Official findings add to concerns about Sweden’s laissez-faire strategy towards the pandemic
    Just 7.3% of Stockholm’s inhabitants had developed Covid-19 antibodies by the end of April, according to a study, raising concerns that the country’s light-touch approach to the coronavirus may not be helping it build up broad immunity.

    The research by Sweden’s public health agency comes as Finland warned it would be risky to welcome Swedish tourists after figures suggested the country’s dea...
  • Reported Coronavirus Cases Top 5 Million Worldwide

    22 May, 2020
    A million new infections were confirmed in less than two weeks.
    More than five million people worldwide have contracted the coronavirus, according to data compiled by The New York Times.

    That figure is just one measure of the pandemic’s global toll. Its persistent rise — the number passed four million less than two weeks ago — reflects not just pathogen’s pernicious spread but also increases in testing.

    Click here for reference





  • Apple and Google release phone technology to notify users of coronavirus exposure

    21 May, 2020
    Apple and Google have released long-awaited smartphone technology to automatically notify people if they might have been exposed to the coronavirus.The companies had announced the unprecedented collaboration to leverage their technology to help trace and contain the spread of coronavirus last month, and say 22 countries and several US states are already planning to build voluntary phone apps using their software.

    The software relies on Bluetooth wireless technology to detect when someo...